Covered recipient · General Payments record

GARY PEARSON OZIER

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1922086065
CMS profile: 268934
Location: WICHITA FALLS, TX

General Payments · PY2018–2021

$5,314.07

Reported across 313 records
CMS publication 2026-01-23

Latest program year · PY2021

$960.32

57 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$960.32	57

By paying entity

PY2021 · sorted by reported total

Paying entity	Amount	Records
Boehringer Ingelheim Pharmaceuticals, Inc.	$191.18	9
Novo Nordisk AS	$173.22	12
Acerta Pharma LLC	$159.75	9
Lilly USA, LLC	$137.83	10
SANOFI-AVENTIS U.S. LLC	$91.71	6
Merck Sharp & Dohme Corporation	$53.16	3
Janssen Pharmaceuticals, Inc	$40.97	2
ABBVIE INC.	$24.88	1
Amarin Pharma Inc.	$22.03	1
Lundbeck LLC	$19.31	1
Biohaven Pharmaceuticals, Inc.	$18.38	1
NOVARTIS PHARMACEUTICALS CORPORATION	$14.63	1
GlaxoSmithKline, LLC.	$13.27	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$1,744.89	100
PY2019	$1,283.97	78
PY2020	$1,324.89	78
PY2021	$960.32	57

Payment records · PY2021 (57)

Sorted by paying entity, then date · as published by CMS

Program year 2021 2018 2019 2020 Record-level detail is published for PY2021; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
AbbVie Inc.	$24.88	11/11/2021	Food and Beverage	Undisputed	01/23/2026	795464065	CMS
Amarin Pharma Inc.	$22.03	06/19/2021	Food and Beverage	Undisputed	01/23/2026	815386519	CMS
AstraZeneca Pharmaceuticals LP	$13.50	02/02/2021	Food and Beverage	Undisputed	01/23/2026	829595073	CMS
AstraZeneca Pharmaceuticals LP	$13.11	03/15/2021	Food and Beverage	Undisputed	01/23/2026	829581435	CMS
AstraZeneca Pharmaceuticals LP	$15.66	04/21/2021	Food and Beverage	Undisputed	01/23/2026	829933591	CMS
AstraZeneca Pharmaceuticals LP	$51.63	04/21/2021	Food and Beverage	Undisputed	01/23/2026	830072445	CMS
AstraZeneca Pharmaceuticals LP	$11.64	06/08/2021	Food and Beverage	Undisputed	01/23/2026	829332817	CMS
AstraZeneca Pharmaceuticals LP	$15.21	06/09/2021	Food and Beverage	Undisputed	01/23/2026	829585705	CMS
AstraZeneca Pharmaceuticals LP	$13.43	07/07/2021	Food and Beverage	Undisputed	01/23/2026	830140355	CMS
AstraZeneca Pharmaceuticals LP	$13.25	09/22/2021	Food and Beverage	Undisputed	01/23/2026	830003711	CMS
AstraZeneca Pharmaceuticals LP	$12.32	11/03/2021	Food and Beverage	Undisputed	01/23/2026	829791417	CMS
Biohaven Pharmaceuticals, Inc.	$18.38	10/13/2021	Food and Beverage	Undisputed	01/23/2026	852584199	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$20.15	01/25/2021	Food and Beverage	Undisputed	01/23/2026	763334098	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$26.60	01/28/2021	Food and Beverage	Undisputed	01/23/2026	763334096	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$31.23	02/25/2021	Food and Beverage	Undisputed	01/23/2026	763334094	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$24.78	03/03/2021	Food and Beverage	Undisputed	01/23/2026	763334092	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$12.83	04/20/2021	Food and Beverage	Undisputed	01/23/2026	763334090	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$25.00	05/12/2021	Food and Beverage	Undisputed	01/23/2026	763334088	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$11.79	05/19/2021	Food and Beverage	Undisputed	01/23/2026	763334086	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$22.89	10/19/2021	Food and Beverage	Undisputed	01/23/2026	763334084	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$15.91	10/28/2021	Food and Beverage	Undisputed	01/23/2026	763334082	CMS
GlaxoSmithKline, LLC.	$13.27	02/01/2021	Food and Beverage	Undisputed	01/23/2026	803055597	CMS
Janssen Pharmaceuticals, Inc	$20.47	02/03/2021	Food and Beverage	Undisputed	01/23/2026	788824639	CMS
Janssen Pharmaceuticals, Inc	$20.50	03/30/2021	Food and Beverage	Undisputed	01/23/2026	788824641	CMS
Lilly USA, LLC	$21.37	01/29/2021	Food and Beverage	Undisputed	01/23/2026	819161703	CMS
Lilly USA, LLC	$11.00	02/24/2021	Food and Beverage	Undisputed	01/23/2026	819134553	CMS
Lilly USA, LLC	$11.45	03/08/2021	Food and Beverage	Undisputed	01/23/2026	819167563	CMS
Lilly USA, LLC	$12.49	04/27/2021	Food and Beverage	Undisputed	01/23/2026	819075745	CMS
Lilly USA, LLC	$17.10	06/10/2021	Food and Beverage	Undisputed	01/23/2026	819101903	CMS
Lilly USA, LLC	$12.27	07/01/2021	Food and Beverage	Undisputed	01/23/2026	819089561	CMS
Lilly USA, LLC	$11.73	10/21/2021	Food and Beverage	Undisputed	01/23/2026	818552445	CMS
Lilly USA, LLC	$12.45	10/26/2021	Food and Beverage	Undisputed	01/23/2026	819101899	CMS
Lilly USA, LLC	$14.14	11/22/2021	Food and Beverage	Undisputed	01/23/2026	819161707	CMS
Lilly USA, LLC	$13.83	12/15/2021	Food and Beverage	Undisputed	01/23/2026	819089565	CMS
Lundbeck LLC	$19.31	10/25/2021	Food and Beverage	Undisputed	01/23/2026	845926923	CMS
Merck Sharp & Dohme Corporation	$19.56	01/13/2021	Food and Beverage	Undisputed	01/23/2026	848575317	CMS
Merck Sharp & Dohme Corporation	$19.05	03/10/2021	Food and Beverage	Undisputed	01/23/2026	848731489	CMS
Merck Sharp & Dohme Corporation	$14.55	11/17/2021	Food and Beverage	Undisputed	01/23/2026	848703497	CMS
Novartis Pharmaceuticals Corporation	$14.63	04/08/2021	Food and Beverage	Undisputed	01/23/2026	813135483	CMS
Novo Nordisk Inc	$20.17	01/15/2021	Food and Beverage	Undisputed	01/23/2026	836094499	CMS
Novo Nordisk Inc	$13.56	01/19/2021	Food and Beverage	Undisputed	01/23/2026	836094501	CMS
Novo Nordisk Inc	$10.81	02/11/2021	Food and Beverage	Undisputed	01/23/2026	836094503	CMS
Novo Nordisk Inc	$12.41	02/23/2021	Food and Beverage	Undisputed	01/23/2026	836094505	CMS
Novo Nordisk Inc	$18.43	03/13/2021	Food and Beverage	Undisputed	01/23/2026	836094507	CMS
Novo Nordisk Inc	$19.64	04/09/2021	Food and Beverage	Undisputed	01/23/2026	836094509	CMS
Novo Nordisk Inc	$8.98	05/03/2021	Food and Beverage	Undisputed	01/23/2026	836094511	CMS
Novo Nordisk Inc	$12.15	05/07/2021	Food and Beverage	Undisputed	01/23/2026	836094513	CMS
Novo Nordisk Inc	$16.06	06/21/2021	Food and Beverage	Undisputed	01/23/2026	836094515	CMS
Novo Nordisk Inc	$13.28	09/28/2021	Food and Beverage	Undisputed	01/23/2026	836094517	CMS
Novo Nordisk Inc	$16.95	10/08/2021	Food and Beverage	Undisputed	01/23/2026	836094519	CMS
Novo Nordisk Inc	$10.78	11/02/2021	Food and Beverage	Undisputed	01/23/2026	836094521	CMS
SANOFI-AVENTIS U.S. LLC	$15.28	03/04/2021	Food and Beverage	Undisputed	01/23/2026	843433169	CMS
SANOFI-AVENTIS U.S. LLC	$12.43	04/13/2021	Food and Beverage	Undisputed	01/23/2026	843433181	CMS
SANOFI-AVENTIS U.S. LLC	$15.12	05/20/2021	Food and Beverage	Undisputed	01/23/2026	843433207	CMS
SANOFI-AVENTIS U.S. LLC	$18.19	06/03/2021	Food and Beverage	Undisputed	01/23/2026	843433215	CMS
SANOFI-AVENTIS U.S. LLC	$16.72	07/16/2021	Food and Beverage	Undisputed	01/23/2026	843433265	CMS
SANOFI-AVENTIS U.S. LLC	$13.97	09/30/2021	Food and Beverage	Undisputed	01/23/2026	843433315	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021
Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.